Discontinuation report ACT PROGESTERONE INJECTION
| Report ID | 256082 |
| Drug Identification Number | 02446820 |
| Brand name | ACT PROGESTERONE INJECTION |
| Common or Proper name | PROGESTERONE INJECTION 500MG/10ML |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PROGESTERONE |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1 |
| ATC code | G03DA |
| ATC description | PROGESTOGENS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2025-04-07 |
| Remaining supply date | 2025-04-07 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-04-29 | French | Compare |
| v1 | 2025-04-29 | English | Compare |
Showing 1 to 2 of 2